Stockreport

Spirair, Developer of the First and Only Minimally Invasive Therapy for Mechanical Correction of Nasal Septal Deviation, Announces Appointment of Benjamin Bishop as Chief Executive Officer...

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com
PDF SOUTH SAN FRANCISCO, Calif., March 12, 2024 BUSINESS WIRE )--Spirairâ„¢, an early-stage company pioneering minimally invasive solutions that help ENTs advance care for th [Read more]